FORMULATION AND EVALUATION OF TOPICAL PENTOXIFYLLINE-HYDROXYPROPYL METHYLCELLULOSE GELS FOR WOUND HEALING APPLICATION
Keywords:Hydroxypropyl methylcellulose, Pentoxifylline, Topical gel, In vitro drug release, Wound healing
Objectives: Oral pentoxifylline shows modest, non-significant effect on the healing rates of chronic wounds. The present research aimed to formulate topical pentoxifylline-hydroxypropyl methylcellulose (HPMC) gels and evaluate their physico-chemical properties, in vitro release characteristics and in vivo wound healing effects.
Methods: Six gel formulations containing pentoxifylline (F1-F6) were prepared using HPMC with varying grades and concentrations. The physicochemical properties of gel formulations were evaluated in term of drug content, spreadability, rheological properties, swelling, and release characteristics. The efficacy of optimized formulation was further evaluated using in vivo excision wound models in rats.
Results:Â The spreadability, flow index and swelling percentage of gel formulations ranged 10.71-12.24 gcm/sec, 0.33-0.91 and 148.61-8011.61%, respectively. The rheological study of the prepared formulations exhibited pseudoplastic behavior, which is a characteristic feature of topical gels. Swelling results of F5 and F6 deduced that the cross-linked structures were formed between the polymeric chains. The in vitro drug release profiles of all formulations were found to be followed Higuchi model. The in vivo evaluation performed using rat excision wound model showed significant difference (P < 0.05) in the percentage reduction of wound size between treatment and control groups. The treatment group exhibited complete healing by day 13 as compared with day 15 in the control group.
Conclusions:Â These findings indicated that F5 gel formulation had demonstrated effective release profile for pentoxifylline. The in vivo results confirmed that F5 has pronounced wound healing effects when employed topically.
Zhang M, Xu YJ, Mengi SA, Arneja AS, Dhalla NS. Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases. Exp Clin Cardiol 2004;9(2):103-11.
Kale R, Bajaj A, Mathew D. Development of matrix diffusion controlled drug delivery system of pentoxifylline. Int J Pharm Pharm Sci 2010;2(1):122â€“30.
Babaei S, Bayat M, Nouruzian M, Bayat M. Pentoxifylline improves cutaneous wound healing in streptozotocin-induced diabetic rats. Eur J Pharmacology 2013;700:165-72.
Jull A, Waters J, Arroll B. Pentoxifylline for treatment of venous leg ulcers: a systematic review. Lancet 2002;359:1550-4.
Dale JJ, Ruckley CV, Harper DR, Gibson B, Nelson EA, Prescott RJ. Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers. British Med J 1999;319:875-78.
Teksin ZS, Agabeyoglu I, Yamac K. Bioavailability of pentoxifylline-chitosan oral matrix tablet in healthy subjects. J Bio Sci Bioengineering 2009;1(4):115â€“20.
Bhowmik D, Gopinath H, Kumar BP, Duraivel S, Kumar KPS. Recent advances in novel topical drug delivery system. The Pharma Innovation 2012;1(9):12-31.
Basha BN, Prakasam K, Goli D. Formulation and evaluation of gel containing fluconazole-antifungal agent. Int J Drug Dev Res 2011;3(4):109-28.
Mohamed MI. Optimization of chlorphenesinemulgel formulation. Am Association Pharm Sci J 2004;6(3):1-7.
Lin CC, Metters AT. Hydrogels in controlled release formulations: Network design and mathematical modeling. Adv Drug Delivery Rev 2006;58:1379-408.
Pygall SR, Kujawinski S, Timmins P, Melia CD. Mechanisms of drug release in citrate buffered HPMC matrices. Int J Pharm 2009;370:110-20.
Pose-Vilarnovo B, Rodriguez-Tenreiro C, Santos JFRD, Vazquez-Doval J, Concheiro A, Alvarez-Lorenzo C, et al. Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets. J Controlled Release 2004;94:351-63.
Joshi SC. Sol-gel behavior of hydroxypropylmethylcellulose (HPMC) in ionic media including drug release. Materials 2011;4:1861â€“905.
Barba AA, Amore M, Chirico S, Lamberti G, Titomanlio G. Swelling of cellulose derivative (HPMC) matrix systems for drug delivery. Carbohydrate Polymers 2009;78:469-74.
Chandak AR, Verma PRP. Development and evaluation of HPMC based matrices for transdermal patches of tramadol. Clinical Res Regulatory Affairs 2008;25(1):13-30.
Patel NA, Patel NJ, Patel RP. Design and evaluation of transdermal drug delivery system for curcumin as an anti-inflammatory drug. Drug Development Industrial Pharm 2009;35:234-42.
Kumar MNVR, Kumar N. Polymeric controlled drug-delivery systems: perspective issues and opprtunities. Drug Development and Industrial Pharm 2001;27(1):1-30.
Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Delivery Rev 2001;48:139-57.
Fu XC, Wang GP, Liang WQ, Chow MSS. Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration. J Control Release 2004;95:209-16.
Jin WG, Shin SC. Preparation and evaluation of procaine gels for the enhanced local anaesthetic action. Arch Pharm Res 2008;31(2):235-41.
Ghosal K, Chakrabarty S, Nanda A. Hydroxypropyl methylcellulose in drug delivery. Der Pharmacia Sinica 2011;2(2):152-68.
Kumar SM, Chandrasekar MJN, Gopinath R, Srinivasan R, Nanjan MJ, Suresh B. In vitro and in vivo studies on HPMC-K-100 M matrices containing naproxen sodium. Drug Delivery 2007;14:163-9.
Meyyanathan SN, Rajan S, Muralidaharan S, Siddaiah MK, Krishnaraj K, Suresh B. Formulation and evaluation of dextromethorphan hydrobromide sustained release tablets. Drug Delivery 2008;15:429-35.
Mitchell SA, Balwinski KM. A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets. J Pharm Sci 2008;97(6):2277-85.
Gwon HJ, Lim YM, Park JS, Nho YC. Evaluation of radiation synthesized Î²-glucan hydrogel wound dressing using rat models. World Academy Sci Engineering Technology 2011;60:684-7.